Suicide is an urgent and growing public health crisis. It was the tenth leading cause of death in the United States in 2015, with over 44,000 deaths, according to the CDC. Studying suicide, and including suicidal or potentially suicidal individuals in clinical research, is an important way to gain valuable data that can advance prevention efforts. Researchers and IRBs may tend to exclude suicidal individuals from research in order to avoid potential risks; however, in order for the research to be scientifically and clinically valuable, it is important that suicidal individuals are not excluded from research unnecessarily. Read more
TAG ARCHIVES FOR mental illness

We need more education about psychiatric IRB processes: An interview with David H. Strauss
Tags:by Avery Avrakotos, education and policy manager
In January, PRIM&R welcomed three new members to its Board of Directors, including David H. Strauss, MD. Dr. Strauss is director of research at the New York State Psychiatric Institute and is vice chair for research administration, ethics, and policy at the Columbia University Department of Psychiatry. Dr. Strauss has been actively involved with PRIM&R for 10 years, [...] Read more
by Julie Fine, Legal Specialist, Legal Division, Pfizer Inc. (Please note: The views presented here are my own and do not reflect positions or policies of Pfizer.)
In the weeks following the 2012 Advancing Ethical Research Conference, what has lingered with me most has been the keynote speech on mental illness and stigma by Elyn Saks, JD, PhD. She discussed how [...] Read more
by Rebecca Boxhorn, JD, Research Associate at the Consortium on Law and Values in Health, Environment & the Life Sciences at the University of Minnesota
In her Pillars of PRIM&R Keynote Address at the 2012 Advancing Ethical Research Conference, Professor Elyn Saks gave a moving and thoughtful [...] Read more